Manufacturing and Production

Showing 15 posts of 5871 posts found.

Chinese API supplier under FDA scrutiny

October 3, 2011 Manufacturing and Production Sichuan Pharmaceutical, pharma manufacturing news

Chinese active ingredient manufacturer Sichuan Pharmaceutical has been sent a warning by the US FDA for failing to sort out …

SHL to speak at the upcoming Drug Delivery Trends symposium in Korea

September 28, 2011 Manufacturing and Production auto injector, autoinjector, drugy delivery, pharmapack

SHL Marketing Director Steven Kaufman will be speaking at the upcoming Primary Packaging and Drug Delivery Trends for Injectables symposium …

MTS Medication Technologies appoints Paul O’Hanlon

September 27, 2011 Manufacturing and Production appointments, manufacturing and production

MTS Medication Technologies has appointed Paul O’Hanlon as managing director of its International Division. He has 27 years of experience …

Lonza signs regenerative medicine deal with Mesoblast

September 27, 2011 Manufacturing and Production Lonza, Mesoblast, pharma manufacturing news

Lonza has entered into a strategic-level alliance with Mesoblast, a specialist in regenerative medicines, which could see the construction of …

SCM Pharma unveils formulation development business

September 27, 2011 Manufacturing and Production SCM Pharma, phamra manufacturing news, pharma manufacturing news

UK contract manufacturer SCM Pharma has set up a formulation development business, thanks to a collaboration with the University of …

Pharma manufacturing news in brief

September 26, 2011 Manufacturing and Production pharma manufacturing news

This week’s roundup includes contract manufacturing updates from CMC Biologics, West-Ward and Aenova, plus a Catalent deal in Japan and …

Healthcare 2025: what the future holds for pharma

September 22, 2011 Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing

We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …

Pfizer to invest $200m in Irish biomanufacturing plant

September 21, 2011 Manufacturing and Production Ireland, Pfizer, pharma manufacturing news

Pfizer is planning to invest around €145 million ($200m) at its biomanufacturing facility in Co Dublin, Ireland, according to the …

Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme

September 20, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PV, Wainwright Associates

A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …

Teva makes commitment to Russian manufacturing facility

September 20, 2011 Manufacturing and Production, Sales and Marketing Russia, Teva

Teva has joined a number of its peers in the pharmaceutical sector and announced plans to build a new manufacturing …

Intersex fish add to concerns about pharma wastewater

September 20, 2011 Business Services, Manufacturing and Production Contamination, pharma manufacturing news

Researchers in France have discovered that wild fish living downstream from a pharmaceutical production plant making steroid drugs show serious …

Alkermes and Elan Drug Technologies complete merger

September 19, 2011 Manufacturing and Production Alkermes, Elan, pharma manufacturing news

The contract manufacturing and development unit of Irish drugmaker Elan has completed a near-$1 billion merger with drug delivery specialist …
GSK McLaren

McLaren alliance to turbocharge GSK research

September 16, 2011 Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news

GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …

First Paediatric Use Marketing Authorisation Granted

September 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Commission has granted the first ever children’s medicine to hold a new Paediatric Use Marketing Authorisation (PUMA). The …

The recast of the Restriction of Hazardous Substances (RoHS) Directive

September 13, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The recast Directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU) will …
The Gateway to Local Adoption Series

Latest content